Skip to main content

Table 2 Characteristics of children with epilepsy

From: Serum α-synuclein and IL-1β are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers?

Epilepsy syndromes

% (N)

Duration of epilepsy (years)

% (N)

Benign epilepsy with centrotemporal spikes

16 (18)

<  1

55 (63)

Benign infantile epilepsy

2 (3)

1~3

13 (15)

Early myoclonic encephalopathy

1 (1)

3~5

8 (9)

Late onset childhood occipital epilepsy

2 (3)

≥ 5

24 (28)

Temporal lobe epilepsy

11 (12)

  

Panayiotopoulos syndrome

4 (4)

  

Generalized epilepsy with febrile seizure plus

7 (8)

Age at seizure onset (years)

% (N)

Childhood absence epilepsy

7 (8)

<  1

34 (39)

Juvenile myoclonic epilepsy

5 (6)

1~3

17 (19)

Lennox Gastaut syndrome

24 (28)

3~5

10 (12)

Idiopathic generalized epilepsy

16 (18)

5~7

12 (14)

Symptomatic generalized epilepsy

5 (6)

≥ 7

27 (31)

Epilepsy etiology

% (N)

Duration of last seizure before blood collection (minutes)

% (N)

Structural

3 (4)

<  5

83 (72)

Genetic

10 (11)

5~10

11 (10)

Dravet syndrome

5

10~30

7 (6)

Lafora diseases

3

≥ 30

14 (12)

Rett syndrome

2

  

Infectious

0

  

Immune

0

  

Neurodevelopmental comorbidities

% (N)

Number of antiepileptic drugs (N)

% (N)

ADHD

18 (16)

1

60 (70)

Autism spectrum disorder

4 (3)

2

15 (17)

Mental retardation

31 (27)

≥ 3

25 (28)

  1. N, number; ADHD, attention deficit hyperactivity disorder